{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:08:43Z","timestamp":1763017723632},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Palifermin has been proven to decrease the frequency of severe oral mucositis in adult patients with sarcoma and metastatic colorectal cancer receiving chemotherapy. The impact of palifermin on the incidence of mucositis in nonhematopoietic stem cell transplantation (HSCT) pediatric population receiving chemotherapy has never been reported to date.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods:<\/jats:title>\n            <jats:p>This is a retrospective analysis of pediatric patients who received palifermin as secondary prophylaxis to prevent chemotherapy-induced mucositis at Memorial Sloan Kettering Cancer Center from January 1, 2008 to 2014. Data from electronic medical records on days to mucositis resolution, use of opioids, use of total parenteral nutrition, duration of hospitalization, and antibiotics are collected and presented here.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 18 patients received palifermin for secondary prophylaxis after developing mucositis from the prior chemotherapy cycle. Mucositis did not reoccur in the subsequent cycle for 13 of the 18 patients. The majority of patients who received palifermin prophylaxis had decreased opioids and antibiotics use and decreased duration of hospitalization. Six of the 7 patients previously requiring total parenteral nutrition due to mucositis had decreased supplemental nutritional needs following the use of palifermin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Palifermin may provide benefit as secondary prophylaxis in pediatric patients to prevent chemotherapy-induced mucositis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000000791","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T15:29:39Z","timestamp":1487950179000},"page":"e177-e182","source":"Crossref","is-referenced-by-count":8,"title":["Retrospective Evaluation of Palifermin Use in Nonhematopoietic Stem Cell Transplant Pediatric Patients"],"prefix":"10.1097","volume":"39","author":[{"given":"Dazhi","family":"Liu","sequence":"first","affiliation":[{"name":"Pharmacy Service"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Seyboth","sequence":"additional","affiliation":[{"name":"Pharmacy Service"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherry","family":"Mathew","sequence":"additional","affiliation":[{"name":"Pharmacy Service"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen W.","family":"Gilheeney","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander J.","family":"Chou","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Drill","sequence":"additional","affiliation":[{"name":"Epidemiology and Statistics, Memorial Sloan Kettering, Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Kobos","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/095530099140258","article-title":"Effects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated mice","volume":"75","author":"Farrell","year":"1999","journal-title":"Int J Radiat Biol"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.22484","article-title":"Updated clinical practice guidelines for the prevention and treatment of mucositis","volume":"109","author":"Keefe","year":"2007","journal-title":"Cancer"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7326\/0003-4819-153-6-201009210-00003","article-title":"Single dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer","volume":"153","author":"Vadhan-Raj","year":"2010","journal-title":"Ann Intern Med"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1200\/JCO.2005.04.1152","article-title":"Palifermin reduced the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy","volume":"24","author":"Rosen","year":"2006","journal-title":"J Clin Oncol"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.bbmt.2012.04.013","article-title":"Phase I study of the tolerability and pharmacokinetics of palifermin in children undergoing allogeneic hematopoietic stem cell transplantation","volume":"18","author":"Srinivasan","year":"2012","journal-title":"Biol blood Marrow Transplant"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bbmt.2016.02.016","article-title":"Safety, pharmacokinetics, and efficacy of palifermin in children and adolescents with acute leukemias undergoing myeloablative therapy and allogeneic hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium trial","volume":"22","author":"Morris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/petr.12192","article-title":"Impact of palifermin on incidence of oral mucositis and healthcare utilization in children undergoing autologous hematopoietic stem cell transplantation for malignant diseases","volume":"18","author":"Vitale","year":"2014","journal-title":"Pediatr Transplant"},{"key":"R8-20230918","first-page":"43","article-title":"Reliability and efficacy of palifermin in prevention and management of oral mucositis in patients with acute lymphoblastic leukemia: a randomized, double-blind controlled clinical trial","volume":"65","author":"Lucchese","year":"2016","journal-title":"Minerva Stomatol"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3109\/10428194.2015.1081192","article-title":"Efficacy and effects of palifermin for the treatment of oral mucositis in patients affected by acute lymphoblastic leukemia","volume":"57","author":"Lucchese","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1592\/phco.27.10.1353","article-title":"Pharmacokinetics of palifermin administered as the standard dose and as a collapsed dose in patients with hematologic malignancies","volume":"27","author":"Zia-Amirhosseini","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"suppl","key":"R11-20230918","first-page":"1995","article-title":"Perspectives on cancer therapy-induced mucosal injury","volume":"100","author":"Spnis","year":"2004","journal-title":"Cancer"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00002820-200312000-00007","article-title":"Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy","volume":"26","author":"Cheng","year":"2003","journal-title":"Cancer Nurs"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1200\/JCO.2011.41.5703","article-title":"Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children\u2019s Oncology Group","volume":"30","author":"Womer","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201705000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:34:37Z","timestamp":1695011677000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201705000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000791","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}